Brighton Jones’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$31.1K Sell
12,085
-5,666
-32% -$16.6K ﹤0.01% 1371
2026
Q2
$57.5K Buy
+17,751
New +$51.9K ﹤0.01% 1360

Other funds holding EDIT

Brighton Jones's EDIT Position: Q3 2026 in Review

Brighton Jones reduced its Editas Medicine (EDIT) stake by 32% in Q3 2026, selling an estimated $16.6K and leaving 12,085 shares worth $31.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1371.

Brighton Jones first reported a position in EDIT in Q2 2026 and has held it in 2 quarters since. The position peaked at $57.5K in Q2 2026. 181 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.

  • Brighton Jones held 12,085 shares of Editas Medicine worth $31.1K as of Q3 2026.
  • Brighton Jones sold 5,666 Editas Medicine shares in Q3 2026, an estimated $16.6K.
  • Editas Medicine made up ﹤0.01% of Brighton Jones's portfolio in Q3 2026, its #1371 holding.
  • Brighton Jones first reported a position in Editas Medicine in Q2 2026 and has held it in 2 quarters since.
  • Brighton Jones's Editas Medicine position peaked at $57.5K in Q2 2026.
  • 181 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.